Tolaney, S. M., Beeram, M., Beck, J. T., Conlin, A. K., Dees, E. C., Dickler, M. N., … Goetz, M. P. (2015). A phase Ib study of abemaciclib with therapies for metastatic breast cancer. In Journal of Clinical Oncology (Vol. 33, pp. 522–522). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.522

Tolaney, Sara M., Muralidhar Beeram, J Thaddeus Beck, Alison Katherine Conlin, Elizabeth Claire Dees, Maura N. Dickler, Teresa L. Helsten, et al. “A phase Ib study of abemaciclib with therapies for metastatic breast cancer.” In Journal of Clinical Oncology, 33:522–522. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.522.

Tolaney SM, Beeram M, Beck JT, Conlin AK, Dees EC, Dickler MN, et al. A phase Ib study of abemaciclib with therapies for metastatic breast cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 522–522.

Tolaney, Sara M., et al. “A phase Ib study of abemaciclib with therapies for metastatic breast cancer.” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 522–522. Crossref, doi:10.1200/jco.2015.33.15_suppl.522.

Tolaney SM, Beeram M, Beck JT, Conlin AK, Dees EC, Dickler MN, Helsten TL, Conkling PR, Edenfield WJ, Richards DA, Turner PK, Cai N, Chan EM, Pant S, Becerra C, Kalinsky K, Puhalla S, Rexer BN, Burris HA, Goetz MP. A phase Ib study of abemaciclib with therapies for metastatic breast cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 522–522.